Literature DB >> 22252005

Recommendations for the use of influenza vaccine in pediatrics.

Susanna Esposito1, Valentina Montinaro, Samantha Bosis, Claudia Tagliabue, Elena Baggi, Nicola Principi.   

Abstract

Every year for the last few decades, the health authorities of most countries throughout the world have issued specific recommendations for the prevention and treatment of pediatric influenza, including recommendations concerning the use of vaccines. However, different evaluations of the importance of the disease and the efficacy of influenza vaccination frequently lead to conflicting recommendations. This is clearly demonstrated not only by the differences in the subjects for whom the vaccine is recommended, but also by the inaccurate manner in which subjects at risk of influenza-related complications are defined. Only further studies that consider the burden of the disease and vaccine efficacy in adequate numbers of healthy children and high-risk children with different chronic underlying diseases can overcome all of the current limitations and significantly improve vaccination coverage in both categories.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252005     DOI: 10.4161/hv.8.1.17957

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  3 in total

Review 1.  Adult vaccination.

Authors:  Kena A Swanson; H Josef Schmitt; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

2.  Vitamin D and influenza vaccination.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2013-02-12       Impact factor: 3.452

3.  Burden of acute otitis media in primary care pediatrics in Italy: a secondary data analysis from the Pedianet database.

Authors:  Paola Marchisio; Luigi Cantarutti; Miriam Sturkenboom; Silvia Girotto; Gino Picelli; Daniele Dona; Antonio Scamarcia; Marco Villa; Carlo Giaquinto
Journal:  BMC Pediatr       Date:  2012-11-29       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.